Friday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com Biotechnology LPATH INC +14.41% HANA BIOSCIENCES INC +12.94% NASTECH PHARM CO +10.86% PIPEX PHARMACEUTICAL +9.96% ALFACELL CORP +8.98% Diagnostic Substances EPICEPT CORPORATION +73.25% MONOGRAM BIOSCIENCES +11.06% AVANT IMMUNOTHERAP +6.90% PALATIN TECH INC +4.66% GENE LOGIC INC…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
by H.S. Ayoub
BioHealth Investor.com
Biotechnology
LPATH INC [LPTN.OB] +14.41%
HANA BIOSCIENCES INC [HNAB] +12.94%
NASTECH PHARM CO [NSTK] +10.86%
PIPEX PHARMACEUTICAL [PPXP.OB] +9.96%
ALFACELL CORP [ACEL] +8.98%
Diagnostic Substances
EPICEPT CORPORATION [EPCT] +73.25%
MONOGRAM BIOSCIENCES [MGRM] +11.06%
AVANT IMMUNOTHERAP [AVAN] +6.90%
PALATIN TECH INC [PTN] +4.66%
GENE LOGIC INC [GLGC] +4.57%
Drug Delivery
DELCATH SYSTEMS INC [DCTH] +6.84%
ALKERMES INC [ALKS] +2.91%
INSITE VISION INC [ISV] +2.60%
NEKTAR THERAPEUTIC [NKTR] +2.55%
NOVEN PHARMACEUTIC [NOVN] +2.35%
Drug Manufacturers
AVANIR PHARMACEUTICL [AVNR] +12.82%
POZEN INC [POZN] +7.32%
PROVECTUS PHARMA [PVCT.OB] +5.10%
OSCIENT PHARMACEUT [OSCI] +4.27%
JAVELIN PHARMACEUTIC [JAV] +3.52%
Drug Related Products
PRESTIGE BRAND HLGS [PBH] +4.41%
MANNATECH INC [MTEX] +1.85%
PACIFICHEALTH LABS [PHLI.OB] +1.74%
PERRIGO COMPANY [PRGO] +1.53%
LABOPHARM INC. [DDSS] +1.43%
Generic Drugs
CATALYST PHARMACEUTI [CPRX] +6.80%
ISOLAGEN INC [ILE] +1.74%
CARACO PHARMA LABS [CPD] +1.69%
WATSON PHARMACEUTCLS [WPI] +1.24%
HI-TECH PHARMACAL [HITK] +0.87%
Medical Appliances & Equipment
Supplies
NON INVASIVE MONITORNG SYS NEW [NIMU.OB] +9.93%
INTUITIVE SURG INC [ISRG] +8.71%
ALIGN TECHNOLOGY I [ALGN] +5.02%
NATUS MEDICAL INC [BABY] +4.50%
STEREOTAXIS, INC. [STXS] +4.11%
Medical Instruments & Supplies
VYTERIS HOLDINGS NV [VYHN.OB] +26.05%
ATRICURE, INC. [ATRC] +7.35%
BIOFORCE NANOSCIENCE [BFNH.OB] +4.90%
CRYOCOR, INC. [CRYO] +4.79%
KENSEY NASH CP [KNSY] +4.57%
Medical Laboratories & Research
SPHERIX INC [SPEX] +4.51%
MEDTOX SCIENTFIC INC [MTOX] +3.07%
OSI PHARMACEUTIC [OSIP] +2.18%
BIO-REFERENCE LAB [BRLI] +2.14%
ENZO BIOCHEM INC [ENZ] +1.24%
http://www.biohealthinvestor.com/
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.